• Home >
  • Publications >
  • Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

1 Dec 2018International Journal of Cancer

DOI : 10.1002/ijc.31842

Authors

Laurent Beziaud, Laura Boullerot, Thi Tran, Laura Mansi, Elodie Lauret Marie-Joseph, Patrice Ravel, Ludger Johannes, Jagadeesh Bayry, Eric Tartour, Olivier Adotévi

Members

LUDGER JOHANNES

Inserm Research Director